HIV Treatment Discontinued By Many In Africa

More than one-third of patients receiving HIV medication in Africa die or discontinue their treatment within two years, according to a study published in PLoS Medicine.Boston University researcher Sydney Rosen and colleagues identified and analyzed scientific reports over the past 7 years that gave details on adult patients remaining on antiviral treatment in 13 sub-Saharan African countries.

Risk Of Prostate Cancer Return Greatly Increased When Treatment Appointments Missed

Men with "low risk" prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring. That is the conclusion of a new study examining more than 15 years of data and nearly 1, 800 patients treated at Fox Chase Cancer Center in Philadelphia.

Ensuring Anti-HIV Drugs Are Taken In Africa

HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.According the results of a new study conducted by Tanzanian physicians and Duke University Medical Center researchers, HIV-infected patients who openly discussed their illness were also more likely to fare better.

Elderly Black Women More Likely To Maintain Hypertension Treatment If They Incorporate Spirituality, Study Finds

Elderly black women who use spirituality might be more successful adhering to a hypertension regimen, according to a study presented on Wednesday at an annual meeting of the American Heart Association in Orlando, Fla., HealthDay/U.S.

Adherence To Antiretroviral Treatment Linked To Health Literacy, Study Finds

HIV-positive people with low health-literacy levels are less likely to understand their medication instructions and, therefore, are less compliant with their antiretroviral treatment regimens, according to a study published in the November issue of the American Journal of Preventive Medicine, Reuters Health reports.

System Of Simplified, Standardized Dosing Instructions For Prescription Medication Container Labels

You have just been prescribed a new medication by your doctor and the container label says: "take one tablet by mouth twice daily for 7 days." How much and how often should you take your medicine? This might be easy for you to answer, but 46 percent of adults misunderstand at least one prescription container label, according to a 2006 study published in Annals of Internal Medicine.

InforMedix Rings Up Med-ePhone - Mobile, Wireless Patient Medication Adherence Solution

InforMedix Holdings, Inc. (OTCBB: IFMX, http://www.informedix.com), developer of the Med-eMonitor™ , an interactive smart pillbox system for medication adherence and health management, is planning to introduce a new device, the Med-ePhone™

Do Make It Personal -- Adherence System Delivers Automated Reminders In Your Voice

If mom is the CEO of her family's healthcare, how well she runs her "company" and manages her own time are vital to her family's health - and to the bottom line of all sectors of the healthcare industry. With pharmaceutical manufacturers losing $30M annually as a result of medication non-compliance and the cost of preventable hospitalizations growing to $15B/year, motivating the steward of a family's care is more important than ever.

Seniors Unable To Afford Prescription Drugs, Study Finds

Two-thirds of California seniors cannot afford their medications, and nine in 10 seniors want to be able to choose which medications are prescribed to them, according to a study published in the December issue of the Journal of the American Geriatrics Society, the Honolulu Advertiser reports.

Ireland Cancer Center Researcher Finds Standard Treatment For Breast Cancer Not Followed

Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment - five years of daily oral use of the chemo-prevention drug Tamoxifen.